Teladoc (TDOC)
NYSE:TDOC
Want to see TDOC full AI Analyst Report?
TDOC Stock Chart & Stats
$5.54
-$0.30(-3.00%)
At close: 4:00 PM EST
$5.54
-$0.30(-3.00%)
Day’s Range― - ―
52-Week Range$4.40 - $9.77
Previous CloseN/A
Volume1.13M
Average Volume (3M)4.62M
Market Cap
$988.32M
Enterprise Value$1.25B
Total Cash (Recent Filing)$781.08M
Total Debt (Recent Filing)$1.04B
Price to Earnings (P/E)―
Beta1.40
Next Earnings
Apr 29, 2026EPS Estimate
-0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding178,396,440
10 Day Avg. Volume3,916,172
30 Day Avg. Volume4,616,568
Financial Highlights & Ratios
PEG Ratio0.08
Price to Book (P/B)0.89
Price to Sales (P/S)0.49
P/FCF Ratio4.32
Enterprise Value/Market Cap1.26
Enterprise Value/Revenue0.49
Enterprise Value/Gross Profit0.71
Enterprise Value/Ebitda129.40
Forecast
1Y Price Target
$7.25Price Target Upside30.87% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering22
EPS Forecast (FY)-0.9
Revenue Forecast (FY)$2.51B
Bulls Say, Bears Say
Bulls Say
Acquisition-driven Valuation UpsideAnalyst notes a peer acquisition of a virtual therapy provider suggests the market may be undervaluing the virtual therapy business, indicating potential upside if similar takeout multiples apply.
Insurance Distribution Improving MarginsAnalyst highlights BetterHelp's shift toward insurance-covered services and greater in-network coverage, which should reduce marketing intensity and improve long-term revenue stability and margins.
Integrated Care Cross-sell And Product ExpansionAnalyst emphasizes a large integrated care membership and new virtual care and chronic condition management products that could enable cross-selling and support sustainable growth.
Bears Say
Behavioral Health Performance DragAnalyst points out that the behavioral health segment remains a drag on revenue and profitability due to ongoing direct-to-consumer challenges, weighing on near-term results.
Execution Risk In Member ConversionAnalyst flags execution risk in shifting members from cash-pay to insurance, which could constrain valuation improvement if conversion proceeds slowly.
Revenue Mix Shift To Visit-fee PricingAnalyst warns that the move from subscription revenue toward visit-fee pricing creates near-term headwinds for revenue growth and keeps integrated care expansion muted until sales efforts and new products gain traction.
Teladoc News
TDOC FAQ
What was Teladoc’s price range in the past 12 months?
Teladoc lowest stock price was $4.40 and its highest was $9.77 in the past 12 months.
What is Teladoc’s market cap?
Teladoc’s market cap is $988.32M.
When is Teladoc’s upcoming earnings report date?
Teladoc’s upcoming earnings report date is Apr 29, 2026 which is in 13 days.
How were Teladoc’s earnings last quarter?
Teladoc released its earnings results on Feb 25, 2026. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.181 by $0.041.
Is Teladoc overvalued?
According to Wall Street analysts Teladoc’s price is currently Undervalued.
Does Teladoc pay dividends?
Teladoc does not currently pay dividends.
What is Teladoc’s EPS estimate?
Teladoc’s EPS estimate is -0.34.
How many shares outstanding does Teladoc have?
Teladoc has 178,396,440 shares outstanding.
What happened to Teladoc’s price movement after its last earnings report?
Teladoc reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.181. Following the earnings report the stock price went up 15.054%.
Which hedge fund is a major shareholder of Teladoc?
Currently, no hedge funds are holding shares in TDOC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Teladoc Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.25 (30.87% Upside)
$7.25 (30.87% Upside)
Blogger Sentiment
Bullish
TDOC Sentiment 66%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 312.1K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.1%
Last 30 Days ▼ 3.7%
Last 30 Days ▼ 3.7%
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-27.62%
12-Months-Change
Fundamentals
Return on Equity
-14.24%
Trailing 12-Months
Asset Growth
-17.61%
Trailing 12-Months
Company Description
Teladoc
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
TDOC Company Deck
TDOC Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call presented a balanced picture: solid margin and cash-flow progress, Integrated Care strength, meaningful operational achievements (debt paydown, ISO certification, AI platform) and early encouraging traction in BetterHelp insurance. Offsetting these positives are persistent top-line pressures (full-year revenue down 1.5%), a notable decline and margin compression at BetterHelp, transitional headwinds from subscription-to-visit shifts, membership risks from policy changes, and some macro/tariff and financing uncertainties. Guidance for 2026 is roughly stable at the midpoint with modest EBITDA growth, reflecting both the progress and remaining execution risks.View all TDOC earnings summariesTDOC Revenue Breakdown
56.44% Teladoc Health Integrated Care
43.56% BetterHelp
TDOC Stock 12 Month Forecast
Average Price Target
$7.25
▲(30.87% Upside)
Technical Analysis
Ownership Overview
0.57% Insiders
21.63% Mutual Funds
0.37% Other Institutional Investors
58.54% Public Companies and Individual Investors